Cutting edge in medical management of cutaneous oncology.

about

FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms.Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.

P2860

Q39796050-2F84C295-31AD-42DE-B41E-1533DE961034 Q51218209-BA7184FC-11C8-4D33-9BE3-9B37E37DB9B5

P2860

Cutting edge in medical management of cutaneous oncology.

Item

http://www.wikidata.org/entity/Q38013803

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cutting edge in medical management of cutaneous oncology.

@en

type

Item

label

Cutting edge in medical management of cutaneous oncology.

@en

prefLabel

Cutting edge in medical management of cutaneous oncology.

@en

P1476

Cutting edge in medical management of cutaneous oncology.

@en

P2093

Adil Daud

http://www.w3.org/2001/XMLSchema#string

Kim Chong

http://www.w3.org/2001/XMLSchema#string

Sarah T Arron

http://www.w3.org/2001/XMLSchema#string

Susana Ortiz-Urda

http://www.w3.org/2001/XMLSchema#string

UCSF High Risk Skin Cancer Program

http://www.w3.org/2001/XMLSchema#string

P2860

Activating Smoothened mutations in sporadic basal-cell carcinoma

Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.

Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.

Mutations of the BRAF gene in human cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor

The Met tyrosine kinase receptor in development and cancer

P304

140-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SDER.2012.03.002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225068269

http://www.w3.org/2001/XMLSchema#string

P698

22640435

http://www.w3.org/2001/XMLSchema#string

P932

3367308

http://www.w3.org/2001/XMLSchema#string

Cutting edge in medical management of cutaneous oncology.

about

P2860

P2860

Cutting edge in medical management of cutaneous oncology.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932